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Coping with diabetes control is difficult for newly 
diagnosed and experienced patients alike. The child 
is often critically ill at diagnosis, and the child and 
the family are faced with a lifelong condition, as well 
as loss of the child as he/she used to be. All suddenly 
face complex technical challenges.[1] Later, the constant repetition 
of testing and insulin administration, unremitting dietary vigilance 
and careful adjustment of every aspect of living with the disease 
potentially become wearisome.[1,2]
Many children over the age of 10 years administer their own 
insulin injections,[3] although some authorities believe that the 
parents should take complete control up to the age of puberty, 
i.e. about 13 or 14 years.[4] However, children vary in their 
development and with regard to the age at which self-treatment 
is appropriate.[3] Parents should not expect that children will 
continue self-injection without parental interest and guidance, 
and will sometimes find themselves having to take over the 
injections again.[3] It must be noted that some patients store 
insulin inappropriately, measure it incorrectly, and neglect home 
blood glucose monitoring (HBGM).
Multiple re-use of disposable insulin syringes for six injections 
is common, the practice being supported by a study in which 
syringes were re-used an average of 6.3 times without infections.[5] 
In Bangladesh, syringes were used 31.3 times on average (maximum 
120 times).[6]
In contrast to the vast literature on the biology of diabetes 
mellitus, little is written on the practical aspects of diabetes care. We 
undertook a study in our clinic at the Dr George Mukhari Academic 
Hospital, Pretoria, South Africa, to establish whether insulin and the 
other necessary equipment are appropriately stored in the homes 
of diabetic patients, and whether paediatric diabetic patients are 
adequately supported by their families.
Methods
Patients attending the paediatric diabetes clinic were interviewed by 
a mother-tongue Tswana speaker in English or Tswana, depending 
on the patient’s preference. Interviews were conducted on the clinic 
day before the patient’s consultation, in a private room, and took 
about 15 minutes. Questions included demographic variables, the 
type of insulin and injection system and where these were kept, 
the measurement of insulin doses, insulin injections and blood 
glucose monitoring tests. Permission for the study was granted by 
the MEDUNSA Research Ethics Committee, MEDUNSA campus, 
University of Limpopo (now Sefako Makgatho Health Sciences 
University), and informed consent was obtained from all subjects. 
Patients could withdraw at any time without its affecting their 
therapy or relationship with the clinic staff, and all information was 
confidential.
Results
Twenty-five subjects were interviewed: nine boys and 16 girls, 
aged 7 - 18 years. The majority (19) were teenagers, four were aged 
≤10 years and two were between 11 and 12 years old. The duration 
of diabetes ranged from 1 month to 9 years, with a median of 4 years. 
Two patients had had diabetes for 1 - 3 months, four for 1 - 2 years, 
12 for 2 - 5 years, and seven for >5 but <10 years.
Glycosylated haemoglobin (HbA1c) values (Table 1) in the study 
subjects were generally unsatisfactory: only two were in the normal 
range, five were slightly elevated, eight fell in the range 9 - 11.9%, and 
five were >12% (in five cases no value could be found). There was a 
tendency for better controlled HbA1c to correspond with a shorter 
duration of diabetes (not statistically significant; p=0.151). Two-
thirds of the patients with a duration of diabetes of <2 years had an 
HbA1c level <9%, while only 21% of those with a longer duration of 
diabetes had similar HbA1c values.
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The majority of the patients (20, 80%) were 
on twice-daily injections with a premixed 
insulin formulation (Actraphane); this 
included all the preteens. Four patients 
administered three injections per day: 
Actraphane before breakfast, soluble insulin 
(Actrapid) before supper, and isophane 
insulin (Protaphane) at 21h00, and only 
one was on a basal-bolus regimen (isophane 
insulin at 21h00 hours, with soluble insulin 
boluses before each meal).
All the households had a refrigerator, and 
none stored insulin in the freezer compart-
ment. At night 88% of the subjects kept the 
insulin in the refrigerator, while more than 
half (56%) did so during the day (Table 2). 
Nine of the subjects (36%) usually carried 
their insulin with them during the day, while 
12 (48%) never did so (Table  3). Eight of 
those who usually carried the insulin with 
them replaced it in the fridge on returning 
home. Three of the patients who were on 
three injections a day did not take insulin to 
school; only one on triple injections and the 
one on basal-bolus therapy did so.
Eighteen of the 25 patients measured 
the insulin themselves, while five mothers 
did so. In one case the duties were shared 
between the mother and the child, and 
in the last, an aunt measured the insulin. 
The four children who were aged 10 years 
or younger were assisted by their mothers, 
but one of these had to administer the 
injection himself. Eight of the nine children 
aged between 11 and 15 years measured 
and administered the insulin themselves; 
in four cases the doses were checked by an 
adult. Altogether, 18 children measured the 
insulin themselves and 20 administered the 
injection themselves; in all cases the doses 
were never checked. In only seven cases 
were the doses ever checked by another 
(Table 4).
Regarding HBGM (Table 5), 14 subjects 
did fingerpricks them selves. The mother 
did this in four cases, and one child assisted 
his mother. About a quarter of the sample 
(six patients) did not perform HBGM at 
all. Measuring and recording the results 
followed approximately the same pattern: 
only five of the 19 patients were assisted 
by an adult in the fingerpricks, eight with 
measuring the results, and four with the 
recording of their results.
Blood glucose control, as measured by 
HbA1c values, was compared between 
the children who had some assistance (in 
injection, HBGM or both) against those 
who had no help. There was no statistically 
significant difference between the two groups.
The measurement of insulin was 
demon strated to the interviewer by 11 of 
the mothers, and in all cases technique 
was appropriate.
Discussion
Our clinic serves a periurban, lower 
socioeconomic, black African population. 
It is assumed, given the absence of reliable 
prevalence data, that type 1 diabetes is 
uncommon in black South Africans. In 
Tanzania, the annual incidence of type 
1 diabetes in children was 1.5/100 000.[7] 
Accordingly, the relatively small number of 
patients with type 1 diabetes in our clinic is 
not surprising.
Our patients’ high HbA1c values reflect the 
lack of resources afforded diabetes mellitus 
at our hospital. The only diabetes educator in 
the hospital has more duties elsewhere than 
in the endocrinology service. It has been 
challenging to obtain analogue insulins, and 
we have not been allowed to use insulin 
pumps. Blood glucose testing strips are all 
too frequently out of stock. These challenges 
affect the choice of insulin therapy for our 
patients.
Giving premixed insulins twice a day 
is clearly not appropriate for the majority 
of patients, most of whom should be on 
Table 1. HbA1c values correlated with duration of diabetes*
Duration 
HbA1c (%)
Total, n<7, n 7 - 8.9, n 9 - 11.9, n >12, n
1 - 3 months 0 0 0 1 1
1 - 1.9 years 2 2 0 1 5
2 - 5.9 years 0 1 5 2 8
6 - 10 years 0 2 3 1 6
Total 2 5 8 5 20
*No HbA1c values available for 5 patients.
Table 2. Where the patients kept their diabetic equipment
Needles 
n subjects (%)
Syringes
n subjects (%)
Other diabetic equipment
n subjects (%)
Bedroom 11 (44) 4 (16) 9 (26)
Kitchen 2 (8) 1 (4) 2 (8)
Refrigerator - 14 (56) -
Dining room 1 (4) 1 (4) 1 (4)
Cupboard 5 (20) 1 (8) 4 (16)
Wardrobe 3 (12) 2 (4) 3 (12)
Drawer 1 (4) 1 (4) -
Box 1 (4) - 1 (4)
Cooler bag 1 (4) 1 (4) 1 (4)
N/A - - 4 (16)
Total 25 (100) 25 (100) 25 (100)
N/A = no regular place of storage. 
Table 3. Insulin storage
Overnight
n subjects (%)
Daytime
n subjects (%)
Refrigerator 21 (84) 14 (56)
Box 1 (4) 2 (8)
Kitchen 1 (4) 1 (4)
Other 2 (8) 1 (4)
Carry* plus fridge  0 6 (24)
Cooler bag plus fridge  0 1 (4)
Total 25 (100) 25 (100)
*Take to school or leisure activity. 
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multiple daily injections. Many more blood 
glucose testing strips should be supplied 
to enable HBGM at least three times a 
day. Insulin pump therapy may make 
management more convenient and avoid 
the many needle pricks, but according to 
Skogsberg et al.,[8] while there is improved 
patient satisfaction there is no difference 
in metabolic control with pump therapy 
v. multiple daily injections. Several meta-
analyses show a statistical difference in 
favour of pump therapy, but only amounting 
to a minimal improvement of 0.2 - 0.3% 
in HbA1c values.[9-12] Similarly, continuous 
subcutaneous glucose sensing devices exist 
to improve blood glucose control, but again 
by a clinically unimportant amount.[13]
It is gratifying that every one of our 
patients had access to a refrigerator. 
However, despite this some failed to store 
their insulin in the refrigerator, in an area 
where day temperatures are usually above 
30°C in summer. Insulin should be stored 
in a refrigerator at 4 - 8°C, and never 
frozen, or alternatively stored at an ambient 
temperature of 15 - 25°C, which requires 
that any remaining insulin be discarded after 
4 weeks.[3]
Assuming that patients who were on 
a twice-daily insulin regimen would not 
need to carry insulin with them, as they 
can have the first injection before breakfast 
and the second before supper, it was not 
clear why seven saw the need to take their 
insulin to school. In contrast, only two of 
the five patients who received three or four 
injections a day carried their insulin with 
them, perhaps because they returned home 
at lunchtime for their additional injection.
While measurement of the insulin dose 
is only moderately reliable when a vial and 
insulin syringe is used, with the Penset 
the correct amount can be dialled, so 
mistakes are usually only found early on 
(or in patients who are partially sighted). 
Indeed the technique was correct in all our 
cases, whether using syringes or the Penset. 
Most of the children had to measure their 
own insulin without help. This is clearly 
inappropriate, even in adolescence, and 
contrasts with a study in the UK where 
parents needed to reassure themselves by 
constant checking, to the extent that some 
children felt that their parents were too 
controlling.[1]
With the modern spring-loaded lancet 
devices, fingerprick testing is quite easy. 
In five cases the children were helped with 
fingerpricks, in eight with measuring their 
blood glucose results, and in four with both 
checking and recording their results.
Conclusion
The children in our study were rarely 
assisted by adults with either their insulin 
injections or HBGM, and are not sufficiently 
supported by their families.
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Table 4. Measurement and administration of insulin
Who measures 
insulin?
n subjects (%)
Who checks 
insulin?
n subjects (%)
Who administers 
insulin?
n subjects (%)
Mother 5 (20) 4 (16) 2 (8)
Mother (sometimes) 0 1 (4) 0
Self 18 (72) 0 20 (80)
Self and mother 1 (4) 0 3 (12)
Aunt 1 (4) 0 0
Sister 0 1 (4) 0
Schoolteacher 0 1 (4) 0
No one 0 18* (72) 0
Total 25 (100) 25* (100) 25 (100)
*This includes the 5 mothers who always measured the insulin.
Table 5. Home blood glucose testing
Finger prick
n subjects (%)
Measure 
results
n subjects (%)
Check result
n subjects (%)
Record results
n subjects (%)
Mother 4 (16) 4 (16) 3 (12) 3 (12)
Mother (sometimes) - - 1 (4) -
Self 14 (56) 11 (44) - 15 (60)
Self and mother 1 (4) 1.5 (6)* - -
Other family member - 2.5 (10)* - 1 (4)
No one 6 (24) 6 (24) 21 (84) 6 (24)
Total 25 (100) 25 (100) 25 (100) 25 (100)
*In one case the patient was supervised either by the mother or another family member.
